Raltegravir in patients with tuberculosis

Lancet Infect Dis. 2021 Jun;21(6):748-749. doi: 10.1016/S1473-3099(20)30937-3. Epub 2021 Mar 2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alkynes
  • Benzoxazines
  • Coinfection*
  • Cyclopropanes
  • HIV Infections* / drug therapy
  • Humans
  • Raltegravir Potassium / therapeutic use
  • Tuberculosis* / drug therapy

Substances

  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Raltegravir Potassium
  • efavirenz